COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam
COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam
复制标题
DOI:
10.1097/00003643-200312000-00005
复制
发表时间:
2003-12-01
影响因子:
3.6
通讯作者:
Spruit, M
中科院分区:
文献类型:
--
作者:
Weber, EWG;Slappendel, R;Spruit, M
Background: In this prospective randomized study we tested the hypothesis that use of more cyclo-oxygenase 2 (COX 2)-selective non-steroidal anti-inflammatory drugs (NSAIDs) can reduce perioperative blood loss compared with non-selective NSAIDs.Methods: Data from 200 patients who underwent total hip replacement were studied. Two NSAIDs were compared: indomethacin 50 mg (n=82) and meloxicam 15 mg (n=86). Both NSAIDs were given orally 1 h before surgery.Results: The two groups were not different with respect to age, gender, ASA class or duration of surgery. When indomethacin was used preoperatively, intraoperative blood loss was 623+/-243 mL (mean+/-SD) and postoperative blood loss 410+/-340 mL. After meloxicam, these values were 524+/-304 mL and 358+/-272 mL, respectively. Total perioperative blood loss after meloxicam was 17% (P